B7 - Radium-223 with concomitant bone-targeting agents in metastatic castration-resistant prostate cancer (CRPC) patients treated in an international early access program (EAP)

Autor: Paganelli, G., Procopio, G., Cabria, M., Cortesi, E., Tucci, M., Farnesi, A., Mango, L., Baldari, S., Hamzaj, A., Caffo, O., Marchetti, P., Dalla Pozza, F., Zucali, P., Barsanti, R., Saad, F.
Zdroj: In Annals of Oncology October 2017 28 Supplement 6:vi18-vi19
Databáze: ScienceDirect